Investor Relations

Investor Relations

Investor Relations

Crowdfunding Campaign

We are grateful to all the investors who supported us during our recent Wefunder crowdfunding campaign. The campaign is now closed, and we are focusing on advancing our clinical programs and preparing for the next stage of growth. For inquiries regarding future investment opportunities, please contact us at info@eliaztherapeutics.com

Take me There

Crowdfunding Campaign

We are grateful to all the investors who supported us during our recent Wefunder crowdfunding campaign. The campaign is now closed, and we are focusing on advancing our clinical programs and preparing for the next stage of growth. For inquiries regarding future investment opportunities, please contact us at info@eliaztherapeutics.com

Take me There

Crowdfunding Campaign

We are grateful to all the investors who supported us during our recent Wefunder crowdfunding campaign. The campaign is now closed, and we are focusing on advancing our clinical programs and preparing for the next stage of growth. For inquiries regarding future investment opportunities, please contact us at info@eliaztherapeutics.com

Take me There

Investor Highlights

$1.9M raised from NIH Grant

$1.9M raised from NIH Grant

$1.9M raised from NIH Grant

$3.4M+ raised via Crowdfunding

$3.4M+ raised via Crowdfunding

$3.4M+ raised via Crowdfunding

For more information regarding investor relations, please contact us below.

Modern office interior with glass walls, wooden accents, and a person walking up a staircase in motion blur.
Modern office interior with glass walls, wooden accents, and a person walking up a staircase in motion blur.
Modern office interior with glass walls, wooden accents, and a person walking up a staircase in motion blur.

Investor Relations

Address

398 Tesconi Ct.
Santa Rosa, CA
95401

Email

info@eliaztherapeutics.com

398 Tesconi Ct
Santa Rosa, CA 95401
United States

Email

info@eliaztherapeutics.com

Technology

Problem/Solution

XGal-3® Device

Company

Team

Press Room

Investor Relations

Research

Publications

Intellectual Property

FCOI

The content on this website is for general informational purposes only and does not constitute medical advice, diagnosis, or treatment. Our product(s) are in development, not approved for commercial use, and not available for sale. Any forward-looking statements reflect current plans and expectations, which may change. If you choose to visit our crowdfunding campaign, please be aware that investing involves risk and should not be considered a guarantee of future outcomes. Mention of third-party organizations does not imply affiliation unless explicitly stated. All trademarks, logos, and technologies referenced are the property of Eliaz Therapeutics or its licensors and may not be used without written permission.

NO MONEY OR OTHER CONSIDERATION IS BEING SOLICITED, AND IF SENT IN RESPONSE, WILL NOT BE ACCEPTED. NO OFFER TO BUY THE SECURITIES CAN BE ACCEPTED AND NO PART OF THE PURCHASE PRICE CAN BE RECEIVED UNTIL THE OFFERING STATEMENT HAS BEEN QUALIFIED BY THE SEC. ANY SUCH OFFER MAY BE WITHDRAWN OR REVOKED, WITHOUT OBLIGATION OR COMMITMENT OF ANY KIND, AT ANY TIME BEFORE NOTICE OF ACCEPTANCE GIVEN AFTER THE DATE OF QUALIFICATION. AN INDICATION OF INTEREST INVOLVES NO OBLIGATION OR COMMITMENT OF ANY KIND. "RESERVING" SECURITIES IS SIMPLY AN INDICATION OF INTEREST.

398 Tesconi Ct
Santa Rosa, CA 95401
United States

Email

info@eliaztherapeutics.com

Technology

Problem/Solution

XGal-3® Device

Company

Team

Press Room

Investor Relations

Research

Publications

Intellectual Property

FCOI

The content on this website is for general informational purposes only and does not constitute medical advice, diagnosis, or treatment. Our product(s) are in development, not approved for commercial use, and not available for sale. Any forward-looking statements reflect current plans and expectations, which may change. If you choose to visit our crowdfunding campaign, please be aware that investing involves risk and should not be considered a guarantee of future outcomes. Mention of third-party organizations does not imply affiliation unless explicitly stated. All trademarks, logos, and technologies referenced are the property of Eliaz Therapeutics or its licensors and may not be used without written permission.

NO MONEY OR OTHER CONSIDERATION IS BEING SOLICITED, AND IF SENT IN RESPONSE, WILL NOT BE ACCEPTED. NO OFFER TO BUY THE SECURITIES CAN BE ACCEPTED AND NO PART OF THE PURCHASE PRICE CAN BE RECEIVED UNTIL THE OFFERING STATEMENT HAS BEEN QUALIFIED BY THE SEC. ANY SUCH OFFER MAY BE WITHDRAWN OR REVOKED, WITHOUT OBLIGATION OR COMMITMENT OF ANY KIND, AT ANY TIME BEFORE NOTICE OF ACCEPTANCE GIVEN AFTER THE DATE OF QUALIFICATION. AN INDICATION OF INTEREST INVOLVES NO OBLIGATION OR COMMITMENT OF ANY KIND. "RESERVING" SECURITIES IS SIMPLY AN INDICATION OF INTEREST.

398 Tesconi Ct
Santa Rosa, CA 95401
United States

Email

info@eliaztherapeutics.com

Technology

Problem/Solution

XGal-3® Device

Company

Team

Press Room

Investor Relations

Research

Publications

Intellectual Property

FCOI

The content on this website is for general informational purposes only and does not constitute medical advice, diagnosis, or treatment. Our product(s) are in development, not approved for commercial use, and not available for sale. Any forward-looking statements reflect current plans and expectations, which may change. If you choose to visit our crowdfunding campaign, please be aware that investing involves risk and should not be considered a guarantee of future outcomes. Mention of third-party organizations does not imply affiliation unless explicitly stated. All trademarks, logos, and technologies referenced are the property of Eliaz Therapeutics or its licensors and may not be used without written permission.

NO MONEY OR OTHER CONSIDERATION IS BEING SOLICITED, AND IF SENT IN RESPONSE, WILL NOT BE ACCEPTED. NO OFFER TO BUY THE SECURITIES CAN BE ACCEPTED AND NO PART OF THE PURCHASE PRICE CAN BE RECEIVED UNTIL THE OFFERING STATEMENT HAS BEEN QUALIFIED BY THE SEC. ANY SUCH OFFER MAY BE WITHDRAWN OR REVOKED, WITHOUT OBLIGATION OR COMMITMENT OF ANY KIND, AT ANY TIME BEFORE NOTICE OF ACCEPTANCE GIVEN AFTER THE DATE OF QUALIFICATION. AN INDICATION OF INTEREST INVOLVES NO OBLIGATION OR COMMITMENT OF ANY KIND. "RESERVING" SECURITIES IS SIMPLY AN INDICATION OF INTEREST.